全文获取类型
收费全文 | 8212篇 |
免费 | 669篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 300篇 |
妇产科学 | 146篇 |
基础医学 | 1368篇 |
口腔科学 | 121篇 |
临床医学 | 957篇 |
内科学 | 1509篇 |
皮肤病学 | 150篇 |
神经病学 | 941篇 |
特种医学 | 166篇 |
外科学 | 912篇 |
综合类 | 44篇 |
一般理论 | 7篇 |
预防医学 | 957篇 |
眼科学 | 138篇 |
药学 | 570篇 |
中国医学 | 22篇 |
肿瘤学 | 521篇 |
出版年
2024年 | 19篇 |
2023年 | 123篇 |
2022年 | 220篇 |
2021年 | 404篇 |
2020年 | 240篇 |
2019年 | 402篇 |
2018年 | 394篇 |
2017年 | 289篇 |
2016年 | 298篇 |
2015年 | 317篇 |
2014年 | 406篇 |
2013年 | 460篇 |
2012年 | 724篇 |
2011年 | 754篇 |
2010年 | 350篇 |
2009年 | 337篇 |
2008年 | 493篇 |
2007年 | 462篇 |
2006年 | 438篇 |
2005年 | 376篇 |
2004年 | 356篇 |
2003年 | 303篇 |
2002年 | 279篇 |
2001年 | 37篇 |
2000年 | 20篇 |
1999年 | 35篇 |
1998年 | 41篇 |
1997年 | 33篇 |
1996年 | 28篇 |
1995年 | 25篇 |
1994年 | 13篇 |
1993年 | 25篇 |
1992年 | 23篇 |
1991年 | 17篇 |
1990年 | 12篇 |
1989年 | 19篇 |
1988年 | 17篇 |
1987年 | 9篇 |
1986年 | 13篇 |
1985年 | 11篇 |
1984年 | 14篇 |
1983年 | 7篇 |
1982年 | 13篇 |
1981年 | 9篇 |
1980年 | 12篇 |
1979年 | 5篇 |
1977年 | 6篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1968年 | 2篇 |
排序方式: 共有8904条查询结果,搜索用时 15 毫秒
91.
92.
Outcomes of patients with differentiated thyroid carcinoma following initial therapy. 总被引:6,自引:0,他引:6
Jacqueline Jonklaas Nicholas J Sarlis Danielle Litofsky Kenneth B Ain S Thomas Bigos James D Brierley David S Cooper Bryan R Haugen Paul W Ladenson James Magner Jacob Robbins Douglas S Ross Monica Skarulis Harry R Maxon Steven I Sherman 《Thyroid》2006,16(12):1229-1242
This analysis was performed to determine the effect of initial therapy on the outcomes of thyroid cancer patients. The study setting was a prospectively followed multi-institutional registry. Patients were stratified as low risk (stages I and II) or high risk (stages III and IV). Treatments employed included near-total thyroidectomy, administration of radioactive iodine, and thyroid hormone suppression therapy. Outcome measures were overall survival, disease-specific survival, and disease-free survival. Near-total thyroidectomy, radioactive iodine, and aggressive thyroid hormone suppression therapy were each independently associated with longer overall survival in high-risk patients. Near-total thyroidectomy followed by radioactive iodine therapy, and moderate thyroid hormone suppression therapy, both predicted improved overall survival in stage II patients. No treatment modality, including lack of radioactive iodine, was associated with altered survival in stage I patients. Based on our overall survival data, we confirm that near-total thyroidectomy is indicated in high-risk patients. We also conclude that radioactive iodine therapy is beneficial for stage II, III, and IV patients. Importantly, we show for the first time that superior outcomes are associated with aggressive thyroid hormone suppression therapy in high-risk patients, but are achieved with modest suppression in stage II patients. We were unable to show any impact, positive or negative, of specific therapies in stage I patients. 相似文献
93.
t(3;17)(q21;q25) in Epstein-Barr virus associated peripheral T-cell lymphoma: a paediatric case 总被引:1,自引:0,他引:1
Frédéric Millot Françoise Brizard Philippe Babin Danielle Canioni Elisabeth Macintyre Guillaume Levard Catherine Gambert Claude Ricour & François Guilhot 《British journal of haematology》1998,100(2):331-334
We describe an immunocompetent 8-year-old boy with a serological profile indicating chronic infection by Epstein-Barr virus (EBV) who developed subcutaneous and pulmonary lesions related to a peripheral T-cell proliferation. No clonal rearrangement of T-cell receptor or immunoglobulin genes was seen. However, the finding of a t(3;17)(q21;q25) in 44 metaphases from one skin lesion demonstrated a clonal origin. We also showed that the proliferative T cells contained EBV genome leading to the diagnosis of EBV-associated peripheral T-cell lymphoma. Further cytogenetic and molecular studies are needed to identify genes implicated in the pathogenesis of this haematological malignancy. 相似文献
94.
Manfroi WC Caramori PR Zago AJ Melchior R Zen V Accordi M Gutierres D Noer C 《International journal of cardiology》2003,90(2-3):153-157
Background: Recently the new specific phosphodiesterase-5 inhibitor sildenafil was introduced into therapy for erectile dysfunction. The hemodynamic effects of sildenafil may be potentially hazardous for patients with cardiac disease. Sildenafil has been reported to augment the hypotensive effects of nitrates. There is sparse information regarding the systemic and pulmonary hemodynamic effects of a single oral dose of sildenafil in patients with stable angina. Methods: Male patients referred for coronary angiography with diagnosis of chronic stable angina were enrolled in this study to assess the acute hemodynamic effects of sildenafil. Patients receiving long-acting or sublingual nitrates for the last 6 h before the study were excluded. Hemodynamic measurement were taken during right and left heart catheterization in the basal state and 60 min after 50 mg of oral sildenafil. Results: Twelve patients (age 53±7 years) were studied. All had stable angina CCS class II or III. Four had previous myocardial infarction. By coronary angiography, seven patients had at least one coronary artery with >70% stenosis, four had at least one with 50–70% stenosis, and one had only intimal irregularities. There were no significant effects of sildenafil on systemic or pulmonary arterial pressure, left ventricle endiastolic pressure, cardiac output, and systemic or pulmonary vascular resistance (P>0.05 for all). No adverse events were observed. Conclusion: A single oral dose of sildenafil had no significant hemodynamic effect in supine patients with stable angina. Isolated administration of sildenafil does not appear to be associated to adverse cardiovascular effects. 相似文献
95.
96.
97.
Ming-Chao Zhong Yan Lu Jin Qian Yingzi Zhu Lingli Dong Astrid Zahn Javier M. Di Noia Danielle Karo-Atar Irah L. King Andr Veillette 《The Journal of experimental medicine》2021,218(3)
Expression of the signaling lymphocytic activation molecule (SLAM)–associated protein (SAP) is critical for the germinal center (GC) reaction and T cell–dependent antibody production. However, when SAP is expressed normally, the role of the associated SLAM family receptors (SFRs) in these processes is nebulous. Herein, we established that in the presence of SAP, SFRs suppressed the expansion of the GC reaction but facilitated the generation of antigen-specific B cells and antibodies. SFRs favored the generation of antigen-reactive B cells and antibodies by boosting expression of pro-survival effectors, such as the B cell antigen receptor (BCR) and Bcl-2, in activated GC B cells. The effects of SFRs on the GC reaction and T cell–dependent antibody production necessitated expression of multiple SFRs, both in T cells and in B cells. Hence, while in the presence of SAP, SFRs inhibit the GC reaction, they are critical for the induction of T cell–mediated humoral immunity by enhancing expression of pro-survival effectors in GC B cells. 相似文献
98.
Ana Paula H. Yokoyama Silvano Wendel Carolina Bonet-Bub Roberta M. Fachini Ana Paula F. Dametto Fernando Blumm Valeria F. Dutra Gabriela T. P. Candelaria Araci M. Sakashita Rafael Rahal Guaragna Machado Rita Fontão-Wendel Nelson Hamerschlak Ruth Achkar Murillo Santucci Cesar Assunção Patrícia Scuracchio Victor Nudelman Laerte Pastore João R. R. Pinho Mirian Dal Ben Roberto Kalil Filho Alexandre R. Marra Mariane T. Amano Esper G. Kallás Alfredo Salim Helito Carlos Roberto Ribeiro de Carvalho Danielle Bastos Araujo Edison Luiz Durigon Anamaria A. Camargo Luiz V. Rizzo Luiz F. L. Reis Jose M. Kutner 《Transfusion》2021,61(8):2295-2306
99.
100.
Romina Lomonaco Eddison Godinez Leiva Fernando Bril Sulav Shrestha Lydia Mansour Jeff Budd Jessica Portillo Romero Siegfried Schmidt Ku-Lang Chang George Samraj John Malaty Katherine Huber Pierre Bedossa Srilaxmi Kalavalapalli Jonathan Marte Diana Barb Danielle Poulton Nada Fanous Kenneth Cusi 《Diabetes care》2021,44(2):399
OBJECTIVEAssess the prevalence of nonalcoholic fatty liver disease (NAFLD) and of liver fibrosis associated with nonalcoholic steatohepatitis in unselected patients with type 2 diabetes mellitus (T2DM).RESEARCH DESIGN AND METHODSA total of 561 patients with T2DM (age: 60 ± 11 years; BMI: 33.4 ± 6.2 kg/m2; and HbA1c: 7.5 ± 1.8%) attending primary care or endocrinology outpatient clinics and unaware of having NAFLD were recruited. At the visit, volunteers were invited to be screened by elastography for steatosis and fibrosis by controlled attenuation parameter (≥274 dB/m) and liver stiffness measurement (LSM; ≥7.0 kPa), respectively. Secondary causes of liver disease were ruled out. Diagnostic panels for prediction of advanced fibrosis, such as AST-to-platelet ratio index (APRI) and Fibrosis-4 (FIB-4) index, were also measured. A liver biopsy was performed if results were suggestive of fibrosis.RESULTSThe prevalence of steatosis was 70% and of fibrosis 21% (LSM ≥7.0 kPa). Moderate fibrosis (F2: LSM ≥8.2 kPa) was present in 6% and severe fibrosis or cirrhosis (F3–4: LSM ≥9.7 kPa) in 9%, similar to that estimated by FIB-4 and APRI panels. Noninvasive testing was consistent with liver biopsy results. Elevated AST or ALT ≥40 units/L was present in a minority of patients with steatosis (8% and 13%, respectively) or with liver fibrosis (18% and 28%, respectively). This suggests that AST/ALT alone are insufficient as initial screening. However, performance may be enhanced by imaging (e.g., transient elastography) and plasma diagnostic panels (e.g., FIB-4 and APRI).CONCLUSIONSModerate-to-advanced fibrosis (F2 or higher), an established risk factor for cirrhosis and overall mortality, affects at least one out of six (15%) patients with T2DM. These results support the American Diabetes Association guidelines to screen for clinically significant fibrosis in patients with T2DM with steatosis or elevated ALT. 相似文献